Annat J - Search Results

1

Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells.

Andoins C, de Fornel D, Annat J, Dutartre P. Andoins C, et al. Among authors: annat j. Transplantation. 1996 Dec 15;62(11):1543-9. doi: 10.1097/00007890-199612150-00003. Transplantation. 1996. PMID: 8970605

2

LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model.

Dutartre P, Annat J, Derrepas P. Dutartre P, et al. Among authors: annat j. Transplant Proc. 1995 Feb;27(1):440-2. Transplant Proc. 1995. PMID: 7879054 No abstract available.

3

Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.

Annat J, Churaqui E, Dutartre P, Bruley-Rosset M. Annat J, et al. Transplantation. 1996 Sep 27;62(6):721-9. doi: 10.1097/00007890-199609270-00004. Transplantation. 1996. PMID: 8824467

4

Both CD45RC+ and negative CD4+ suppressor cells are present in the rat cardiac allograft LF 08-0299-induced tolerance model.

Andoins C, de Fornel D, Annat J, Dutartre P. Andoins C, et al. Among authors: annat j. Transplant Proc. 1997 Feb-Mar;29(1-2):1282-4. doi: 10.1016/s0041-1345(96)00516-7. Transplant Proc. 1997. PMID: 9123307 No abstract available.

5

T cell repertoire expression in murine recipients of bone marrow transplant after LF 08-0299 (Tresperimus) administration.

Annat J, Dutartre P. Annat J, et al. Transpl Immunol. 1998 Dec;6(4):217-24. doi: 10.1016/s0966-3274(98)80011-7. Transpl Immunol. 1998. PMID: 10342735

6

Implications of prostaglandin E2 synthesis and phospholipase C activation in potentiation of T-cell proliferation by LF 1695.

Derrepas P, Annat J, Dutartre P, Pascal M. Derrepas P, et al. Among authors: annat j. Int J Immunopharmacol. 1991;13(5):555-63. doi: 10.1016/0192-0561(91)90076-j. Int J Immunopharmacol. 1991. PMID: 1783469

7

LF 08-0299 protects murine recipients of minor antigen disparate donor marrow from lethal graft-versus-host disease.

Bruley-Rosset M, Churaqui E, Annat J, Dutartre P. Bruley-Rosset M, et al. Among authors: annat j. Ann N Y Acad Sci. 1995 Dec 29;770:373-5. doi: 10.1111/j.1749-6632.1995.tb31073.x. Ann N Y Acad Sci. 1995. PMID: 8597379 No abstract available.

8

LF 08-0299 protects murine recipients of minor antigen disparate donor bone marrow from lethal graft-versus-host disease.

Bruley-Rosset M, Churaqui E, Annat J, Dutartre P. Bruley-Rosset M, et al. Among authors: annat j. Transplant Proc. 1996 Dec;28(6):3114-6. Transplant Proc. 1996. PMID: 8962208 No abstract available.

9

Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 1. Structural modifications of the hydroxyglycine moiety.

Lebreton L, Annat J, Derrepas P, Dutartre P, Renaut P. Lebreton L, et al. Among authors: annat j. J Med Chem. 1999 Jan 28;42(2):277-90. doi: 10.1021/jm980431g. J Med Chem. 1999. PMID: 9925733

10

Structure-immunosuppressive activity relationships of new analogues of 15-deoxyspergualin. 2. Structural modifications of the spermidine moiety.

Lebreton L, Jost E, Carboni B, Annat J, Vaultier M, Dutartre P, Renaut P. Lebreton L, et al. Among authors: annat j. J Med Chem. 1999 Nov 18;42(23):4749-63. doi: 10.1021/jm991043x. J Med Chem. 1999. PMID: 10579839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters